BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rojas-Quintero J, Wang X, Tipper J, Burkett PR, Zuñiga J, Ashtekar AR, Polverino F, Rout A, Yambayev I, Hernández C, Jimenez L, Ramírez G, Harrod KS, Owen CA. Matrix metalloproteinase-9 deficiency protects mice from severe influenza A viral infection. JCI Insight 2018;3:99022. [PMID: 30568032 DOI: 10.1172/jci.insight.99022] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Boyd DF, Wilson TL, Thomas PG. One hundred years of (influenza) immunopathology. Adv Virus Res 2020;107:247-84. [PMID: 32711731 DOI: 10.1016/bs.aivir.2020.06.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Petito E, Falcinelli E, Paliani U, Cesari E, Vaudo G, Sebastiano M, Cerotto V, Guglielmini G, Gori F, Malvestiti M, Becattini C, Paciullo F, De Robertis E, Bury L, Lazzarini T, Gresele P; COVIR study investigators. Association of Neutrophil Activation, More Than Platelet Activation, With Thrombotic Complications in Coronavirus Disease 2019. J Infect Dis 2021;223:933-44. [PMID: 33280009 DOI: 10.1093/infdis/jiaa756] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 25.0] [Reference Citation Analysis]
3 Hazra S, Chaudhuri AG, Tiwary BK, Chakrabarti N. Matrix metallopeptidase 9 as a host protein target of chloroquine and melatonin for immunoregulation in COVID-19: A network-based meta-analysis. Life Sci 2020;257:118096. [PMID: 32679150 DOI: 10.1016/j.lfs.2020.118096] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
4 Lai Y, Han T, Lao Z, Li G, Xiao J, Liu X. Phillyrin for COVID-19 and Influenza Co-infection: A Potential Therapeutic Strategy Targeting Host Based on Bioinformatics Analysis. Front Pharmacol 2021;12:754241. [PMID: 34803696 DOI: 10.3389/fphar.2021.754241] [Reference Citation Analysis]
5 Pedrina J, Stambas J. Targeting the Host Response: Can We Manipulate Extracellular Matrix Metalloproteinase Activity to Improve Influenza Virus Infection Outcomes? Front Mol Biosci 2021;8:703456. [PMID: 34291090 DOI: 10.3389/fmolb.2021.703456] [Reference Citation Analysis]
6 Karakurt HU, Pİr P. Integration of transcriptomic profile of SARS-CoV-2 infected normal human bronchial epithelial cells with metabolic and protein-protein interaction networks. Turk J Biol 2020;44:168-77. [PMID: 32595353 DOI: 10.3906/biy-2005-115] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
7 Rudd JM, Pulavendran S, Ashar HK, Ritchey JW, Snider TA, Malayer JR, Marie M, Chow VTK, Narasaraju T. Neutrophils Induce a Novel Chemokine Receptors Repertoire During Influenza Pneumonia. Front Cell Infect Microbiol 2019;9:108. [PMID: 31041196 DOI: 10.3389/fcimb.2019.00108] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
8 Connolly E, Morgan DJ, Franklin M, Simpson A, Shah R, Brand OJ, Jagger CP, Casulli J, Mohamed K, Grabiec AM, Hussell T. Neurturin regulates the lung-resident macrophage inflammatory response to viral infection. Life Sci Alliance 2020;3:e202000780. [PMID: 33020210 DOI: 10.26508/lsa.202000780] [Reference Citation Analysis]
9 Niethamer TK, Stabler CT, Leach JP, Zepp JA, Morley MP, Babu A, Zhou S, Morrisey EE. Defining the role of pulmonary endothelial cell heterogeneity in the response to acute lung injury. Elife 2020;9:e53072. [PMID: 32091393 DOI: 10.7554/eLife.53072] [Cited by in Crossref: 40] [Cited by in F6Publishing: 21] [Article Influence: 20.0] [Reference Citation Analysis]
10 Charzewski Ł, Krzyśko KA, Lesyng B. Structural characterisation of inhibitory and non-inhibitory MMP-9-TIMP-1 complexes and implications for regulatory mechanisms of MMP-9. Sci Rep 2021;11:13376. [PMID: 34183752 DOI: 10.1038/s41598-021-92881-x] [Reference Citation Analysis]
11 Okamori S, Ishii M, Asakura T, Suzuki S, Namkoong H, Kagawa S, Hegab AE, Yagi K, Kamata H, Kusumoto T, Ogawa T, Takahashi H, Yoda M, Horiuchi K, Hasegawa N, Fukunaga K. ADAM10 partially protects mice against influenza pneumonia by suppressing specific myeloid cell population. Am J Physiol Lung Cell Mol Physiol 2021;321:L872-84. [PMID: 34523355 DOI: 10.1152/ajplung.00619.2020] [Reference Citation Analysis]
12 Brokhman I, Watkin AMT, Bacher JC, Glazer SA, Galea AM. A Novel Method for the Production of an Autologous Anti-Inflammatory and Anti-Catabolic Product (Cytorich) from Human Blood: A Prospective Treatment for the COVID-19-Induced Cytokine Storm. Med Sci Monit 2021;27:e934365. [PMID: 34795200 DOI: 10.12659/MSM.934365] [Reference Citation Analysis]
13 Beigel JH, Nam HH, Adams PL, Krafft A, Ince WL, El-Kamary SS, Sims AC. Advances in respiratory virus therapeutics - A meeting report from the 6th isirv Antiviral Group conference. Antiviral Res. 2019;167:45-67. [PMID: 30974127 DOI: 10.1016/j.antiviral.2019.04.006] [Cited by in Crossref: 79] [Cited by in F6Publishing: 67] [Article Influence: 26.3] [Reference Citation Analysis]
14 Jia S, Wu J, Zhou W, Liu X, Guo S, Zhang J, Liu S, Ni M, Meng Z, Liu X, Zhang X, Wang M. A network pharmacology-based strategy deciphers the multitarget pharmacological mechanism of Reduning injection in the treatment of influenza. European Journal of Integrative Medicine 2020;36:101111. [DOI: 10.1016/j.eujim.2020.101111] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Kalil AC, Thomas PG. Influenza virus-related critical illness: pathophysiology and epidemiology. Crit Care 2019;23:258. [PMID: 31324202 DOI: 10.1186/s13054-019-2539-x] [Cited by in Crossref: 89] [Cited by in F6Publishing: 89] [Article Influence: 29.7] [Reference Citation Analysis]
16 Boyd DF, Allen EK, Randolph AG, Guo XJ, Weng Y, Sanders CJ, Bajracharya R, Lee NK, Guy CS, Vogel P, Guan W, Li Y, Liu X, Novak T, Newhams MM, Fabrizio TP, Wohlgemuth N, Mourani PM, Wight TN, Schultz-Cherry S, Cormier SA, Shaw-Saliba K, Pekosz A, Rothman RE, Chen KF, Yang Z, Webby RJ, Zhong N, Crawford JC, Thomas PG; PALISI Pediatric Intensive Care Influenza (PICFLU) Investigators. Exuberant fibroblast activity compromises lung function via ADAMTS4. Nature 2020;587:466-71. [PMID: 33116313 DOI: 10.1038/s41586-020-2877-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 12.0] [Reference Citation Analysis]
17 Xin Y, Chen S, Tang K, Wu Y, Guo Y. Identification of Nifurtimox and Chrysin as Anti-Influenza Virus Agents by Clinical Transcriptome Signature Reversion. Int J Mol Sci 2022;23:2372. [PMID: 35216485 DOI: 10.3390/ijms23042372] [Reference Citation Analysis]
18 Iverson E, Kaler L, Agostino EL, Song D, Duncan GA, Scull MA. Leveraging 3D Model Systems to Understand Viral Interactions with the Respiratory Mucosa. Viruses 2020;12:E1425. [PMID: 33322395 DOI: 10.3390/v12121425] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]